Biodexa Pharmaceuticals Plc ADR (BDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 06-2020 | 12-2019 | 06-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,491 | -21,616 | -12,878 | -5,682 | -20,062 |
| Depreciation Amortization | 1,563 | 711 | 1,641 | 828 | 1,935 |
| Other Working Capital | -2,000 | -647 | 2,296 | 23 | -1,939 |
| Other Operating Activity | 16,986 | 12,757 | 655 | -1,033 | 2,113 |
| Operating Cash Flow | $-11,942 | $-8,795 | $-8,286 | $-5,864 | $-17,953 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -85 | -110 | -396 | -26 | -292 |
| Net Acquisitions | 0 | N/A | 0 | -1,218 | 12,359 |
| Other Investing Activity | 3,390 | 1 | -4,465 | -8 | 2 |
| Investing Cash Flow | $3,305 | $-109 | $-4,861 | $-1,252 | $12,069 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 3,960 | 478 | 23,920 | 15,729 | -8,639 |
| Financing Cash Flow | $3,960 | $478 | $23,920 | $15,729 | $-8,639 |
| Exchange Rate Effect | 335 | 237 | 189 | -85 | 25 |
| Beginning Cash Position | 14,032 | 13,561 | 2,992 | 3,012 | 17,625 |
| End Cash Position | 9,689 | 5,371 | 13,954 | 11,540 | 3,127 |
| Net Cash Flow | $-4,342 | $-8,190 | $10,962 | $8,528 | $-14,497 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,942 | -8,795 | -8,286 | -5,864 | -17,953 |
| Free Cash Flow | -11,942 | -8,795 | -8,286 | -5,864 | -17,953 |